Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
01 2MIDAS PHARMA GMBH Ingelheim am Rhein DE
02 1COHANCE LIFESCIENCES LIMITED Hyderabad IN
03 1Chemische Fabrik Berg GmbH Bitterfeld-Wolfen DE
04 1DR. REDDY'S LABORATORIES LIMITED Hyderabad IN
05 1APITORIA PHARMA PRIVATE LIMITED Hyderabad IN
06 1EXCELLA GMBH & CO. KG Feucht DE
07 1NIFTY LABS PVT. LTD. Hyderabad IN
08 1PORTON PHARMACEUTICAL LTD. Chongqing CN
09 1SANECA PHARMACEUTICALS A.S. Hlohovec SK
01 8Doxazosin mesilate
02 1Doxazosin mesilate, Form-I
03 1Doxazosin mesilate, Process 2
01 1China
02 4Germany
03 4India
04 1Slovakia
01 9Valid
02 1Withdrawn by Holder
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
Certificate Number : CEP 2017-111 - Rev 03
Status : Valid
Issue Date : 2023-09-20
Type : Chemical
Substance Number : 2125
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Certificate Number : CEP 2010-312 - Rev 03
Status : Valid
Issue Date : 2023-10-27
Type : Chemical
Substance Number : 2125
Certificate Number : CEP 2022-316 - Rev 00
Status : Valid
Issue Date : 2024-04-29
Type : Chemical
Substance Number : 2125
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Certificate Number : R1-CEP 2008-164 - Rev 05
Status : Valid
Issue Date : 2023-05-15
Type : Chemical
Substance Number : 2125
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
Certificate Number : CEP 2024-112 - Rev 00
Status : Valid
Issue Date : 2024-08-05
Type : Chemical
Substance Number : 2125
Certificate Number : CEP 2006-289 - Rev 04
Status : Valid
Issue Date : 2024-08-20
Type : Chemical
Substance Number : 2125
Certificate Number : R1-CEP 2008-328 - Rev 02
Status : Valid
Issue Date : 2021-06-09
Type : Chemical
Substance Number : 2125
Certificate Number : CEP 2022-257 - Rev 00
Status : Valid
Issue Date : 2024-04-15
Type : Chemical
Substance Number : 2125
Certificate Number : R1-CEP 2011-097 - Rev 02
Status : Valid
Issue Date : 2020-12-17
Type : Chemical
Substance Number : 2125
Certificate Number : R1-CEP 2007-244 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2014-08-28
Type : Chemical
Substance Number : 2125
A Doxazosin Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Doxazosin Mesylate, including repackagers and relabelers. The FDA regulates Doxazosin Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Doxazosin Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Doxazosin Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Doxazosin Mesylate supplier is an individual or a company that provides Doxazosin Mesylate active pharmaceutical ingredient (API) or Doxazosin Mesylate finished formulations upon request. The Doxazosin Mesylate suppliers may include Doxazosin Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Doxazosin Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Doxazosin Mesylate CEP of the European Pharmacopoeia monograph is often referred to as a Doxazosin Mesylate Certificate of Suitability (COS). The purpose of a Doxazosin Mesylate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Doxazosin Mesylate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Doxazosin Mesylate to their clients by showing that a Doxazosin Mesylate CEP has been issued for it. The manufacturer submits a Doxazosin Mesylate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Doxazosin Mesylate CEP holder for the record. Additionally, the data presented in the Doxazosin Mesylate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Doxazosin Mesylate DMF.
A Doxazosin Mesylate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Doxazosin Mesylate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Doxazosin Mesylate suppliers with CEP (COS) on PharmaCompass.
We have 8 companies offering Doxazosin Mesylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?